Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biocept Inc BIOCQ

Healthcare Biotechnology
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular... see more

Recent & Breaking News (GREY:BIOCQ)

Biocept Expands Worldwide Microchannel Patent Protection to South Korea

GlobeNewswire December 15, 2014

Biocept Appoints Experienced Physician as Medical Director

GlobeNewswire December 3, 2014

Biocept Reports Third Quarter 2014 Financial Results

GlobeNewswire November 13, 2014

Biocept Launches Lung Cancer Offering

GlobeNewswire November 12, 2014

Biocept, Inc. Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results

GlobeNewswire November 6, 2014

Biocept and Rosetta Genomics Collaborate to Evaluate microRNAs From Circulating Tumor Cells

GlobeNewswire October 13, 2014

Biocept Expands Collaboration With MD Anderson Cancer Center

GlobeNewswire October 7, 2014

Biocept to Present at the 13th Annual BIO Investor Forum

GlobeNewswire September 30, 2014

Biocept Granted Patent in China for Its Microfluidic Channel Technology Used to Capture Circulating Tumor Cells

GlobeNewswire September 18, 2014

Biocept to Present at Upcoming Investor Conferences

GlobeNewswire September 4, 2014

Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe

GlobeNewswire September 3, 2014

Biocept Provides Second Quarter Operational Update

GlobeNewswire August 14, 2014

Biocept Appoints Managed Care Expert to Lead Contract and Reimbursement Strategy

GlobeNewswire August 6, 2014

Biocept Expands Breast Cancer Offering

GlobeNewswire June 2, 2014

Biocept Announces National Sales Force

GlobeNewswire May 19, 2014

Biocept, Inc. Closes $10 Million Term Loan Facility With Oxford Finance LLC

GlobeNewswire May 7, 2014

Biocept Launches Clinical Research Services for Biomarker Detection in Circulating Tumor DNA

GlobeNewswire April 28, 2014

30+ Leading Small-Cap Companies to Present at RedChip Global Online CEO Conference, April 23-24

GlobeNewswire April 21, 2014

Biocept Appoints Commercialization Leader to Implement Global Diagnostic Sales Program

GlobeNewswire March 24, 2014

Biocept, Inc. to Present at the 26th Annual ROTH Conference

GlobeNewswire March 5, 2014